12/2, 2025
기사
Inside China’s Early-Phase Trial Boom: Novotech’s China Managing Director Andy Liu Weighs In
In a recent PharmaBoardroom interview, Andy Liu, Novotech’s Managing Director for China, explains how regulatory reforms since 2015 and fa...
자세히 알아보세요